NOVO NORDISKDRN forum
NVO massive over reaction to the downside here. This is a buy under $80
NOVO_B Get rekt by HS? Even after "meh" earnings 😅
NOVO_B buy area at 105
NVO 133 level presents a favorable opportunity for entry, contingent upon a decisive breach of the more robust support situated between 120 and 125.
NVO to the mooooon
NVO Next NOVO Golden Level at F 261.8 (161.8 USD)GOLDEN X GOLDEN
NVO 123-124 presented a favorable buying opportunity with relatively robust support. Can we anticipate reaching 134 or even new highs before the end of next week?
NVO America will only get fatter. Might as well make money off it
NVO This is one of those relatively rare stocks that are riding huge momentum from the 4Hr to the 1 month AND are pre-announcing profitability AND have a solid "disruption" narrative with the repurposing f their diabetes drug into a safe and effective long t4erm weight reduction vanity drug (although it hasn't yet eliminated the need to inject weekly....they're working aggressively on a capsule or tablet and, if and when they succeed (which is likely to be in the next year), it should transform NVO from a very robustly profitable biopharma stock to a mega-corporate, patented 'thin pill" manufacturer. Sort of like Prozac before the patent expired. People in the US, let alone remaining developed countries want to be happy (Prazac upon patented release 35 yers ago) and thin (NVO's patented drug now). So while the paradigm of it's sub-sector makes it a strong stock that is reaching the limits of value per share (and a premium), well, with the 800lb gorilla in the room of think Americans everywhere eating whenever they choose and remaining thin, the enormous value of having cornered the weight loss/maintenance market (estimated to be in the 100's of billions in added revenue per quarter) makes this price analogous to entering AMZN when it was a bookstore. After AMZN's paradigm shift (and even before its AWS) there was a 2000x profit per share over the next decade, Ann, try as they might, the press and competitors have only come with 1 headwind: that insurance won't cover the cost of the drug. Well, two European nations have had insurance coverage cleared. And the US market for weigh loss is enormous as a discretionary expense. Even Weight Watchers became a NasDaq multibillion dollar venture based on pamphlets and coaches. NVO can and will offer a once a week self-injection that keeps a person thin. People in the US will go into debt to buy such a thing. Pill form? NVO has the non-trivial probability of becoming a mega-cap. So buying no is. a bargain. Just my opinion.